Comparative Haemodynamic Responses to the First Dose of Short- and Long-acting ACE Inhibitors in Patients with Congestive Heart Failure

References

• Carson P. Pharmacologic treatment of congestive heart failure. Clin Cardiol 1996;19:2271–7
   Google Scholar
• Young JB. Heart failure, ventricular remodelling and the reninangiotensin system: insights from recently completed clinical trials. Eur Heart J 1993;14:14–17
   PubMedGoogle Scholar
• Pitt B. Therapy of left ventricular dysfunction: implications of recent therapeutic trials and future directions for therapy. Schweiz Med Wochenschr 1993;123:342–8
   PubMedGoogle Scholar
• Guidelines for the evaluation and management of Heart Failure. ACC/AHA task force report. J Am Coll Cardiol 1995;26:1376–98
   PubMedGoogle Scholar
• SOLVD (Studies of Left Ventricular Dysfunction) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325: 294–302
   Google Scholar
• Swedberg K, Held P, Kjekshus J et al. (on behalf of the Consensus II Study Group). Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med 1992;327:678–84
   Google Scholar
• Fletcher RD, Cintron GB, Johnson G, Orndorff J, Carson P, Cohn JN. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. The VHeFT II VA Cooperative Studies Group. Circulation 1993;87:V149–V155
   Google Scholar
• Pfeffer MA, Braunwald E, Moyé LA et al. (on behalf of the SAVE Investigators). Effect of captopril on mortality and morbidity in patients with LVD after myocardial infarction. Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669–77
   Google Scholar
• Manche A, Galea J, Busuttil W. Tolerance to ACE inhibitors after cardiac surgery. Eur J Cardiothorac Surg 1999;15:55–60
   PubMed Web of Science ®Google Scholar
• Andersson F, Cline C, Ryden-Bergsten T, Erhardt L. Angiotensin converting enzyme (ACE) inhibitors and heart failure. The consequences of underprescribing. Pharmacoecon 1999;15:535–50
   PubMed Web of Science ®Google Scholar
• Luzier AB, DiTusa L. Underutilization of ACE inhibitors in heart failure. Pharmacotherapy 1999;19:1296–307
   PubMed Web of Science ®Google Scholar
• Farnsworth A. Angiotensin-converting enzyme inhibitors in heart failure: target dose prescription in elderly patients. Letter. Age Ageing 1998;27:653–4
   PubMed Web of Science ®Google Scholar
• Murray JJ. Failure to practice evidence-based medicine: why do physicians not treat patients with heart failure with angiotensin-converting enzyme inhibitors? Eur Heart J 1998;19:L15–L21
   PubMedGoogle Scholar
• Smith NL, Psaty BM, Pitt B, Garg R, Gottdiener JS, Heckbert SR. Temporal patterns in the medical treatment of congestive heart failure with angiotensin-converting enzyme inhibitors in older adults, 1989 through 1995. Arch Intern Med 1998;158:1074–80
   PubMed Web of Science ®Google Scholar
• Roe CM, Motheral BR, Teitelbaum F, Rich MW. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. Am Heart J 1999;138:818–25
   PubMed Web of Science ®Google Scholar
• Philbin EF. Factors determining angiotensin-converting enzyme inhibitor utilization in heart failure in a community setting. Clin Cardiol 1998;21:103–8
   PubMed Web of Science ®Google Scholar
• Reid J, Lees KR, Squire I. First-dose hypotension and ACE inhibitors in heart failure. ADIS International, 1995
   Google Scholar
• Hasford J, Bussman WD, Delius W et al. First dose hypotension with enalapril and prazosin in congestive heart failure. Int J Cardiol 1991;31:287–94
   PubMed Web of Science ®Google Scholar
• Cleland JGF, Dargie HJ, McAlpine H et al. Severe hypotension after first dose of enalapril in heart failure. Br Med J 1985;291:1309–12
   PubMed Web of Science ®Google Scholar
• Captopril Multicenter Research Group. A placebo-controlled trial of captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 1983; 2:755–63
   PubMed Web of Science ®Google Scholar
• Di Carlo L, Chatterjee K, Parmley WW et al. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol 1983;2:865–71
   PubMed Web of Science ®Google Scholar
• Packer M, Lee WH, Yushak M et al. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med 1986;315:847–53
   PubMed Web of Science ®Google Scholar
• The Task Force of the Working Group of Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure. Eur H J 2001;22:1527–60
   PubMed Web of Science ®Google Scholar
• Chinese Cardiac Study Collaborative Group. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995;345:686–7
   PubMed Web of Science ®Google Scholar
• ISIS-4 (Fourth International Study on Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 1995;345: 669–85
   PubMed Web of Science ®Google Scholar
• Otterstadt JE, Froeland G. First-dose blood pressure response in mild-to-moderate heart failure: a randomised double-blind study comparing enalapril with lisinopril by 24-h non-invasive blood pressure monitoring. Am J Cardiol 1992;70:132–4
   PubMedGoogle Scholar
• Squire IB, MacFadyen RJ, Lees KR et al. Hemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure. Br J Clin Pharmacol 1994;38:117–23
   PubMed Web of Science ®Google Scholar
• MacFadyen RJ, Lees KR, Reid JL. Differences in first-dose response to angiotensin-converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J 1991;66:206–11
   PubMedGoogle Scholar
• Reid JL, MacFadyen RJ, Squire IB, Lees KR. Angiotensin-converting enzyme inhibitors in heart failure: blood pressure changes after the first dose. Am Heart J 1993;126:794–7
   PubMed Web of Science ®Google Scholar
• Squire IB, MacFadyen RJ, Reid JL et al. Differing early blood pressure and renin-angiotensin system responses to the first dose of angiotensin-converting enzyme inhibitors in congestive heart failure. J Cardiovasc Pharmacol 1996;27:657–66
   PubMed Web of Science ®Google Scholar
• Haiat R, Piot O, Gallois H, Hanania G. Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril. French General Hospitals National College of Cardiologists. J Cardiovasc Pharmacol 1999;33:952–9
   Google Scholar
• Navookarasu NT, Rahman ARA, Abdullah I. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience. Int J Clin Pract 1999;53:25–30
   PubMed Web of Science ®Google Scholar
• Vitovec J, Spinar J. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Eur J Heart Fail 2000;2:299–304
   PubMed Web of Science ®Google Scholar
• MacFadyen RJ, Lees RL, Reid JL. Blood pressure responses to low-dose oral ester or intravenous diacid angiotensin converting enzyme inhibitors. J Hypertens 1991;9:S376–S377
   Web of Science ®Google Scholar
• Harrigan JR, Hughes DM, Meredith PA, Reid JL. Characterization of the effects of prodrug concentration on the in vitro potency of the metabolites of the five ACE inhibitors (abstract). Eur J Clin Pharmacol 1989;36:A186
   Google Scholar
• The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429–35
   Google Scholar
• Owens P, O’Brien E. Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Heart 1999;82:477–81
   PubMed Web of Science ®Google Scholar
• Burckharrt BA, Mukerji V, Alpert MA. Coronary artery slow flow associated with angina pectoris and hypotension: a case report. Angiology 1998;49:483–7
   PubMed Web of Science ®Google Scholar
• Finnery FA Jr, Witkin L, Fazerkas JF. Cerebral hemodynamics during cerebral ischemia induced by acute hypotension. J Clin Invest 1959;33:1227
   Google Scholar
• Todd PA, Fitton A. Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991;42:90–114
   PubMed Web of Science ®Google Scholar
• Morgan T. Twenty four hours BP control. Which is best trough: peak ratios or ABPM? Br J Card. 1995(Suppl 1):7–9
   Google Scholar